Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

biochemical recurrence

  • Diuresis During <sup>18</sup>F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial
    You have access
    Diuresis During 18F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II Trial
    Ismaheel O. Lawal, Aliza Mushtaq, Ashesh B. Jani, Manali Rupji, Vishal R. Dhere, Sagar A. Patel, Mehmet A. Bilen, Pretesh R. Patel, Nikhil T. Sebastian, Jeffrey M. Switchenko, David M. Schuster and Charles Marcus
    Journal of Nuclear Medicine February 1, 2025, 66 (2) 230-237; DOI: https://doi.org/10.2967/jnumed.124.268574
  • Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
    You have access
    Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
    Lilit Schweiger, Tobias Maurer, Ricarda Simon, Thomas Horn, Matthias Heck, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 67-72; DOI: https://doi.org/10.2967/jnumed.124.268151
  • Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CT
    You have access
    Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT
    Sherrington Li, Andrew Nguyen, William Counter, Nikeith C. John, Jeremiah De Leon, George Hruby, Anthony M. Joshua, Phillip Stricker, Megan Crumbaker, Narjess Ayati, Lyn Chan, Zahra Sabahi, Mina Swiha, Andrew Kneebone, Keith Wong, Victor Liu, Shikha Sharma, Shikha Agrawal and Louise M. Emmett
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1371-1375; DOI: https://doi.org/10.2967/jnumed.124.267881
  • True-Positive <sup>18</sup>F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study
    Open Access
    True-Positive 18F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study
    Mark T. Fleming, Rick Hermsen, Andrei S. Purysko, Albert Chau, Phillip Davis, Brian F. Chapin and David M. Schuster
    Journal of Nuclear Medicine July 1, 2024, 65 (7) 1080-1086; DOI: https://doi.org/10.2967/jnumed.123.267271
  • Delayed Imaging Improves Lesion Detectability in [<sup>99m</sup>Tc]Tc-PSMA-I&amp;S SPECT/CT in Recurrent Prostate Cancer
    You have access
    Delayed Imaging Improves Lesion Detectability in [99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer
    Christoph Berliner, Lisa Steinhelfer, Maythinee Chantadisai, Markus Kroenke, Daniel Koehler, Randi Pose, Peter Bannas, Sophie Knipper, Matthias Eiber and Tobias Maurer
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1036-1042; DOI: https://doi.org/10.2967/jnumed.122.265252
  • Feasibility of <sup>99m</sup>Tc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
    You have access
    Feasibility of 99mTc-MIP-1404 for SPECT/CT Imaging and Subsequent PSMA-Radioguided Surgery in Early Biochemically Recurrent Prostate Cancer: A Case Series of 9 Patients
    Daniel Koehler, Markus Sauer, Susanne Klutmann, Ivayla Apostolova, Wencke Lehnert, Lars Budäus, Sophie Knipper and Tobias Maurer
    Journal of Nuclear Medicine January 1, 2023, 64 (1) 59-62; DOI: https://doi.org/10.2967/jnumed.122.263892
  • Validation of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
    You have access
    Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
    Markus Kroenke, Lilit Schweiger, Thomas Horn, Bernhard Haller, Kristina Schwamborn, Alexander Wurzer, Tobias Maurer, Hans-Jürgen Wester, Matthias Eiber and Isabel Rauscher
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1809-1814; DOI: https://doi.org/10.2967/jnumed.121.263707
  • <sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
    You have access
    68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
    Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1822-1828; DOI: https://doi.org/10.2967/jnumed.122.263897
  • Predictors of <sup>18</sup>F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
    You have access
    Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
    Esther Mena, Steven P. Rowe, Joanna H. Shih, Liza Lindenberg, Baris Turkbey, Aloyse Fourquet, Frank I. Lin, Stephen Adler, Philip Eclarinal, Yolanda L. McKinney, Deborah E. Citrin, William Dahut, Bradford J. Wood, Richard Chang, Elliot Levy, Maria Merino, Michael A. Gorin, Martin G. Pomper, Peter A. Pinto, Janet F. Eary, Peter L. Choyke and Kenneth J. Pienta
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1184-1190; DOI: https://doi.org/10.2967/jnumed.121.262347
  • <sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
    You have access
    18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
    Harun Ilhan, Markus Kroenke, Alexander Wurzer, Marcus Unterrainer, Matthias Heck, Claus Belka, Karina Knorr, Thomas Langbein, Isabel Rauscher, Nina-Sophie Schmidt-Hegemann, Kilian Schiller, Peter Bartenstein, Hans-Jürgen Wester and Matthias Eiber
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1208-1214; DOI: https://doi.org/10.2967/jnumed.121.262861

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
SNMMI

© 2025 SNMMI

Powered by HighWire